Suven Life Sciences reports two-fold rise in Q4 net profit

Suven Life Sciences has reported results for fourth quarter ended March 31, 2011.

On the standalone basis, the company has posted a rise of 137.14% in its net profit at Rs 8.30 crore for the quarter ended March 31, 2012 as compared to Rs 3.50 crore for the same quarter in the previous year. Total income has increased by 36.96% at Rs 62.51 crore for quarter under review as compared to Rs 45.64 crore for the quarter ended March 31, 2011.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.